BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35289732)

  • 21. Knowledge, attitudes, practices, and perceived risk of cervical cancer among Kenyan women: brief report.
    Sudenga SL; Rositch AF; Otieno WA; Smith JS
    Int J Gynecol Cancer; 2013 Jun; 23(5):895-9. PubMed ID: 23694983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Day or night, no matter what, I will go": Women's perspectives on challenges with follow-up care after cervical cancer screening in Iquitos, Peru: a qualitative study.
    Morse RM; Jurczuk M; Brown J; Jara LEC; Meza G; López EJR; Tracy JK; Gravitt PE; Paz-Soldan VA;
    BMC Womens Health; 2023 May; 23(1):293. PubMed ID: 37259075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
    Charkhchi P; Schabath MB; Carlos RC
    J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
    Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
    BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Timeliness and follow-up patterns of cervical cancer detection in a cohort of medically underserved California women.
    Tabnak F; Müller HG; Wang JL; Zhang W; Howell LP
    Cancer Causes Control; 2010 Mar; 21(3):411-20. PubMed ID: 20043203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of management of high-grade cervical lesions in a single visit: a randomized controlled trial.
    Brewster WR; Hubbell FA; Largent J; Ziogas A; Lin F; Howe S; Ganiats TG; Anton-Culver H; Manetta A
    JAMA; 2005 Nov; 294(17):2182-7. PubMed ID: 16264159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results.
    Elit L; Krzyzanowska M; Saskin R; Barbera L; Razzaq A; Lofters A; Yeritsyan N; Bierman A
    Can Fam Physician; 2012 Jan; 58(1):e22-31. PubMed ID: 22267636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical cancer screening research in the PROSPR I consortium: Rationale, methods and baseline findings from a US cohort.
    Kamineni A; Tiro JA; Beaber EF; Silverberg MJ; Wheeler CM; Chao CR; Chubak J; Skinner CS; Corley DA; Kim JJ; Balasubramanian BA; Paul Doria-Rose V;
    Int J Cancer; 2019 Mar; 144(6):1460-1473. PubMed ID: 30353911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing Disparities in Cervical Cancer Screening with Pap Test by Disability Types.
    Orji AF; Roess AA
    J Cancer Educ; 2024 Feb; 39(1):39-49. PubMed ID: 37782432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of cervical cancer occurrences in New Zealand 2008-2012.
    Hider P; Dempster-Rivett K; Williman J; Dempster-Rivett M; Sadler L; McLeod M; Miller A; Sykes P
    N Z Med J; 2018 Mar; 131(1472):53-63. PubMed ID: 29565936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychiatric morbidity and cervical cancer screening: a retrospective population-based case-cohort study.
    Ouk M; Edwards JD; Colby-Milley J; Kiss A; Swardfager W; Law M
    CMAJ Open; 2020; 8(1):E134-E141. PubMed ID: 32161045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of US Preventive Services Task Force Guideline-Concordant Cervical Cancer Screening Rates and Reasons for Underscreening by Age, Race and Ethnicity, Sexual Orientation, Rurality, and Insurance, 2005 to 2019.
    Suk R; Hong YR; Rajan SS; Xie Z; Zhu Y; Spencer JC
    JAMA Netw Open; 2022 Jan; 5(1):e2143582. PubMed ID: 35040970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden.
    Wang J; Andrae B; Sundström K; Ploner A; Ström P; Elfström KM; Dillner J; Sparén P
    PLoS Med; 2017 Oct; 14(10):e1002414. PubMed ID: 29065127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of health care coverage in cervical cancer screening follow-up: findings from a cross-sectional study in Colombia.
    Garcés-Palacio IC; Altarac M; Kirby R; McClure LA; Mulvihill B; Scarinci IC
    Int J Gynecol Cancer; 2010 Oct; 20(7):1232-9. PubMed ID: 21495237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of, and beliefs about, access to screening facilities and cervical cancer screening behaviors among low-income women in New Jersey.
    Silvera SAN; Bandera EV; Jones BA; Kaplan AM; Demisse K
    Cancer Causes Control; 2020 Jan; 31(1):43-49. PubMed ID: 31720918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individual-level and community-level determinants of cervical cancer screening among Kenyan women: a multilevel analysis of a Nationwide survey.
    Tiruneh FN; Chuang KY; Ntenda PAM; Chuang YC
    BMC Womens Health; 2017 Nov; 17(1):109. PubMed ID: 29141612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.